OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Addex Pharmaceuticals Ltd/  CH0029850754  /

Nasdaq Other OTC
2/3/2022  12:00:00 AM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
0.9900USD - 100
Turnover: -		 -Bid Size: - -Ask Size: - 15.26 mill.USD - -
GlobeNewswire 8/27 Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Coll...
GlobeNewswire 7/22 Addex’s Partner Discontinues ADX71149 development in Epilepsy
GlobeNewswire 7/15 Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International ...
GlobeNewswire 7/12 Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
GlobeNewswire 7/1 Addex Shareholders Approve All Resolutions at Annual General Meeting
GlobeNewswire 6/6 Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire 6/5 Addex Convenes Annual General Meeting 2024
GlobeNewswire 5/31 Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire 5/8 Addex to Present at Bio€quity Europe 2024
GlobeNewswire 4/29 Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
GlobeNewswire 4/19 Addex to Present at the Swiss Biotech Day 2024
GlobeNewswire 4/18 Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 4/11 Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire 4/3 Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire 3/14 Addex to Present at the Bio-Europe Spring 2024 Conference
GlobeNewswire 1/31 Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire 1/9 Addex to Present at the Swiss Equities Baader Conference
GlobeNewswire 1/5 Addex to Present at Biotech Showcase™ 2024
GlobeNewswire 12/14/2023 Addex Creates Treasury Shares
GlobeNewswire 11/29/2023 Addex Reports Q3 2023 Financial Results and Provides Corporate Update
GlobeNewswire 11/28/2023 Addex Convenes Extraordinary General Meeting
GlobeNewswire 11/23/2023 Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
GlobeNewswire 11/14/2023 Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients
GlobeNewswire 11/8/2023 Addex Regains Nasdaq Listing Compliance
GlobeNewswire 11/2/2023 Addex Announces Participation in the Bio-Europe 2023 Conference